ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study

Enrolling by invitationOBSERVATIONAL
Enrollment

583

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

October 31, 2025

Conditions
Paroxysmal Atrial Fibrillation
Trial Locations (26)

10029

Mount Sinai, Icahn School of Medicine, New York

10075

Northwell Health, New York

17043

Pinnacle Health at Harrisburg Hospital, Wormleysburg

18901

Doylestown Hospital, Doylestown

19104

Hospital of the University of Pennsylvania, Philadelphia

Presbyterian University of Pennsylvania Medical Center, Philadelphia

21287

Johns Hopkins Hospital, Baltimore

23219

Virginia Commonwealth University Health System, Richmond

29406

Trident Medical Center, Charleston

29425

Medical University of South Carolina, Charleston

30322

Emory University Hospital, Atlanta

35243

Grandview Medical Center, Birmingham

37205

St. Thomas Research Institute, LLC, Nashville

37232

Vanderbilt University Medical Center, Nashville

64111

St. Luke's Hospital of Kansas City, Kansas City

68114

Nebraska Methodist Hospital, Omaha

78705

Texas Cardiac Arrhythmia Research, Austin

83702

St. Lukes Idaho Cardiology Associates, Boise

85006

Banner University Medical Center Phoenix, Phoenix

92037

Scripps Memorial Hospital, La Jolla

94010

Mills Peninsula Health Services, Burlingame

97225

Providence St. Vincent Medical Center, Portland

94143-0628

University of California, San Francisco, San Francisco

20010-2975

Washington Hospital Center, Washington D.C.

02114

Massachusetts General Hospital (MGH), Boston

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT06526546 - ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study | Biotech Hunter | Biotech Hunter